These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30295491)

  • 1. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice?
    Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W
    Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 3. Supramolecular Nanotheranostics.
    Chen X; Zheng G; Cheng J; Yang YY
    Theranostics; 2019; 9(11):3014-3016. PubMed ID: 31244939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
    Chen Y; Wu Y; Sun B; Liu S; Liu H
    Small; 2017 Mar; 13(10):. PubMed ID: 28075057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supramolecular cancer nanotheranostics.
    Zhou J; Rao L; Yu G; Cook TR; Chen X; Huang F
    Chem Soc Rev; 2021 Feb; 50(4):2839-2891. PubMed ID: 33524093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomaterials with Supramolecular Assembly Based on AIE Luminogens for Theranostic Applications.
    Song N; Zhang Z; Liu P; Yang YW; Wang L; Wang D; Tang BZ
    Adv Mater; 2020 Dec; 32(49):e2004208. PubMed ID: 33150632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA nanostructure-based imaging probes and drug carriers.
    Zhan P; Jiang Q; Wang ZG; Li N; Yu H; Ding B
    ChemMedChem; 2014 Sep; 9(9):2013-20. PubMed ID: 25045126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Molecular Machines in Nanotheranostics.
    Yu G; Yung BC; Zhou Z; Mao Z; Chen X
    ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
    Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
    Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled Nucleic Acid Nanostructures for Cancer Theranostic Medicines.
    Fu J; Stankeviciute G; Oh SW; Collins J; Zhong Y; Zhang T
    Curr Top Med Chem; 2017; 17(16):1815-1828. PubMed ID: 27875979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-modulated self-assembly as a versatile strategy for tumor supramolecular nanotheranostics.
    Li S; Zou Q; Xing R; Govindaraju T; Fakhrullin R; Yan X
    Theranostics; 2019; 9(11):3249-3261. PubMed ID: 31244952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Polymer Nanoparticles Programmed via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.
    Li N; Xiang MH; Liu JW; Tang H; Jiang JH
    Anal Chem; 2018 Nov; 90(21):12951-12958. PubMed ID: 30303006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
    Muthu MS; Mehata AK; Viswanadh MK
    Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
    [No Abstract]   [Full Text] [Related]  

  • 16. Precisely Tailored DNA Nanostructures and their Theranostic Applications.
    Zhu B; Wang L; Li J; Fan C
    Chem Rec; 2017 Dec; 17(12):1213-1230. PubMed ID: 28608630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dually pH/Reduction-Responsive Vesicles for Ultrahigh-Contrast Fluorescence Imaging and Thermo-Chemotherapy-Synergized Tumor Ablation.
    Zhu A; Miao K; Deng Y; Ke H; He H; Yang T; Guo M; Li Y; Guo Z; Wang Y; Yang X; Zhao Y; Chen H
    ACS Nano; 2015 Aug; 9(8):7874-85. PubMed ID: 26181349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.